Metabolic syndrome and immune-related adverse events

Key Points

• Immune-related adverse events are increased in individuals with metabolic syndrome, impacting treatment outcomes.
• Evidence shows that 30% of patients with metabolic syndrome experienced significant immune-related adverse events.
• Analysis of clinical data from various healthcare settings highlights the importance of monitoring metabolic syndrome biomarkers.
• This association emphasizes the need for targeted interventions to manage metabolic syndrome to improve patient safety.